{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T20:41:42Z","timestamp":1794343302718,"version":"4.9.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012895","name":"Zoetis Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012895","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Veterinary and Animal Science"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.vas.2026.100872","type":"journal-article","created":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T15:39:33Z","timestamp":1789832373000},"page":"100872","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Prospective, randomized, placebo-controlled, multicenter, double-blind, parallel-group, registration field trial evaluating izenivetmab, a caninized anti-nerve growth factor monoclonal antibody, administered quarterly to dogs with naturally occurring osteoarthritis"],"prefix":"10.1016","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7207-7002","authenticated-orcid":false,"given":"Hilde","family":"Moyaert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gina M.","family":"Michels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Berlamont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Akkermans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard D.","family":"Hummel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jezaniah Kira S.","family":"Tena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria J","family":"Corral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"Gisbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawn M.","family":"Cleaver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R","family":"Stegemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vas.2026.100872_bib0001","doi-asserted-by":"crossref","first-page":"220","DOI":"10.3389\/fvets.2020.00220","article-title":"Risk factors for canine osteoarthritis and its predisposing arthropathies: A systemic review","volume":"7","author":"Anderson","year":"2020","journal-title":"Frontiers in Veterinary Science"},{"key":"10.1016\/j.vas.2026.100872_bib0002","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/nri2747","article-title":"Strategies and challenges for the next generation of therapeutic antibodies","volume":"10","author":"Beck","year":"2010","journal-title":"Nature Reviews Immunology"},{"key":"10.1016\/j.vas.2026.100872_bib0003","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/j.1532-950X.2014.12142.x","article-title":"The canine orthopedic index. Step 1: devising the items","volume":"43","author":"Brown","year":"2014","journal-title":"Veterinary Surgery"},{"key":"10.1016\/j.vas.2026.100872_bib0004","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1532-950X.2014.12141.x","article-title":"The canine orthopedic index. Step 2: psychometric testing","volume":"43","author":"Brown","year":"2014","journal-title":"Veterinary Surgery"},{"key":"10.1016\/j.vas.2026.100872_bib0006","doi-asserted-by":"crossref","first-page":"631","DOI":"10.2460\/ajvr.68.6.631","article-title":"Development and psychometric testing of an instrument designed to measure chronic pain in dogs with osteoarthritis","volume":"68","author":"Brown","year":"2007","journal-title":"American Journal of Veterinary Research"},{"key":"10.1016\/j.vas.2026.100872_bib0007","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.2460\/javma.233.8.1278","article-title":"Ability of the canine brief pain inventory to detect response to treatment in dogs with osteoarthritis","volume":"233","author":"Brown","year":"2008","journal-title":"Journal of the American Veterinary Medical Association"},{"key":"10.1016\/j.vas.2026.100872_bib0005","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1532-950X.2014.12162.x","article-title":"The canine orthopedic index. Step 3: responsiveness testing","volume":"43","author":"Brown","year":"2014","journal-title":"Veterinary Surgery"},{"key":"10.1016\/j.vas.2026.100872_bib0008","series-title":"The canine brief pain inventory","author":"Brown","year":"2017"},{"key":"10.1016\/j.vas.2026.100872_bib0009","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.2460\/ajvr.74.12.1467","article-title":"Power of treatment success definitions when the canine brief pain inventory is used to evaluate carprofen treatment for the control of pain and inflammation in dogs with osteoarthritis","volume":"74","author":"Brown","year":"2013","journal-title":"American Journal of Veterinary Research"},{"key":"10.1016\/j.vas.2026.100872_bib0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1759720X211022149","article-title":"Non-steroidal anti-inflammatory drugs in the pharmacological management of osteoarthritis in the very old: Prescribe or proscribe?","volume":"13","author":"Cadet","year":"2021","journal-title":"Therapeutic Advances in Musculoskeletal Disease"},{"key":"10.1016\/j.vas.2026.100872_bib0011","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1136\/bmj.310.6977.452","article-title":"The number needed to treat: A clinically useful measure of treatment effect","volume":"310","author":"Cook","year":"1995","journal-title":"British Medical Journal"},{"key":"10.1016\/j.vas.2026.100872_bib0012","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.vaa.2021.08.001","article-title":"A prospective, randomized, blinded, placebo-controlled multisite clinical study of bedinvetmab, a canine monoclonal antibody targeting nerve growth factor, in dogs with osteoarthritis","volume":"48","author":"Corral","year":"2021","journal-title":"Veterinary Anaesthesia and Analgesia"},{"key":"10.1016\/j.vas.2026.100872_bib0013","unstructured":"EMEA. (2000). VICH topic GL9. good clinical practice. the european agency for the evaluation of medicinal products. Retrieved from VICH Topic GL9 (GCP). Accessed October 1, 2025."},{"key":"10.1016\/j.vas.2026.100872_bib0014","unstructured":"EMA Committee for Veterinary Medicinal Products. (2023). Combined VeDDRA list of clinical terms for reporting suspected adverse events in animals and humans to veterinary medicinal products. Retrieved from https:\/\/www.ema.europa.eu\/en\/documents\/regulatory-procedural-guideline\/combined-veterinary-dictionary-drug-regulatory-activities-veddra-list-clinical-terms-reporting-en.pdf Accessed November 6; 2024."},{"key":"10.1016\/j.vas.2026.100872_bib0015","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1177\/19476035241293048","article-title":"Regression to the mean: Statistical bias can mislead interpretation in cartilage and osteoarthritis clinics and research","volume":"16","author":"Emanuel","year":"2024","journal-title":"Cartilage"},{"key":"10.1016\/j.vas.2026.100872_bib0016","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-52324-9","article-title":"Prevalence of radiographic appendicular osteoarthritis and associated clinical signs in young dogs","volume":"14","author":"Enomoto","year":"2024","journal-title":"Scientific Reports"},{"key":"10.1016\/j.vas.2026.100872_bib0017","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-026-37626-4","article-title":"A noninferiority trial evaluating the efficacy of bedinvetmab compared to grapiprant for osteoarthritis-pain in dogs using force plate gait analysis","volume":"16","author":"Enomoto","year":"2026","journal-title":"Scientific Reports"},{"key":"10.1016\/j.vas.2026.100872_bib0018","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s11030-015-9625-z","article-title":"The present state of the art in expression, production and characterization of monoclonal antibodies","volume":"20","author":"Gaughan","year":"2015","journal-title":"Molecular Diversity"},{"key":"10.1016\/j.vas.2026.100872_bib0019","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1111\/jvim.16291","article-title":"Frunevetmab, a felinized anti-nerve growth factor monoclonal antibody, for the treatment of pain from osteoarthritis in cats","volume":"35","author":"Gruen","year":"2021","journal-title":"Journal of Veterinary Internal Medicine"},{"key":"10.1016\/j.vas.2026.100872_bib0020","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1748-5827.2009.00765.x","article-title":"Validation of a client-based clinical metrology instrument for the evaluation of canine elbow osteoarthritis","volume":"50","author":"Hercock","year":"2009","journal-title":"The Journal of Small Animal Practice"},{"key":"10.1016\/j.vas.2026.100872_bib0021","doi-asserted-by":"crossref","first-page":"727","DOI":"10.2460\/ajvr.70.6.727","article-title":"Psychometric testing of the Helsinki chronic pain index by completion of a questionnaire in Finnish by owners of dogs with chronic signs of pain caused by osteoarthritis","volume":"70","author":"Hielm-Bjorkman","year":"2009","journal-title":"American Journal of Veterinary Research"},{"key":"10.1016\/j.vas.2026.100872_bib0022","doi-asserted-by":"crossref","DOI":"10.3389\/fvets.2025.1502218","article-title":"A randomised, parallel-group clinical trial comparing bedinvetmab to meloxicam for the management of canine osteoarthritis","volume":"12","author":"Innes","year":"2025","journal-title":"Frontiers in Veterinary Science"},{"key":"10.1016\/j.vas.2026.100872_bib0023","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S0195-5616(97)50076-3","article-title":"Osteoarthritis. Joint anatomy, physiology, and pathobiology","volume":"27","author":"Johnston","year":"1997","journal-title":"Veterinary Clinics of North America: Small Animal Practice"},{"key":"10.1016\/j.vas.2026.100872_bib0024","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/j.cvsm.2008.08.001","article-title":"Nonsurgical management of osteoarthritis in dogs","volume":"38","author":"Johnston","year":"2008","journal-title":"Veterinary Clinics of North America: Small Animal Practice"},{"key":"10.1016\/j.vas.2026.100872_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.tvjl.2021.105733","article-title":"Laboratory safety evaluation of bedinvetmab, a canine anti-nerve growth factor monoclonal antibody, in dogs","volume":"276","author":"Krautmann","year":"2021","journal-title":"The Veterinary Journal"},{"key":"10.1016\/j.vas.2026.100872_bib0026","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/s41584-019-0202-1","article-title":"Spontaneous dog osteoarthritis \u2013 a One Medicine vision","volume":"15","author":"Meeson","year":"2019","journal-title":"Nature Reviews Rheumatology"},{"key":"10.1016\/j.vas.2026.100872_bib0027","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1111\/vde.12376","article-title":"A blinded, randomized, placebo-controlled, dose determination trial of lokivetmab (ZTS-00103289), a caninized, anti-canine IL-31 monoclonal antibody in client owned dogs with atopic dermatitis","volume":"27","author":"Michels","year":"2016","journal-title":"Veterinary Dermatology"},{"key":"10.1016\/j.vas.2026.100872_bib0028","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/vde.12364","article-title":"A blinded, randomized, placebo-controlled trial of the safety of lokivetmab (ZTS-00103289), a caninized anti-canine IL-31 monoclonal antibody in client-owned dogs with atopic dermatitis","volume":"27","author":"Michels","year":"2016","journal-title":"Veterinary Dermatology"},{"key":"10.1016\/j.vas.2026.100872_bib0029","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.vaa.2023.06.003","article-title":"A prospective, randomized, double-blind, placebo-controlled multisite, parallel-group field study in dogs with osteoarthritis conducted in the United States of America evaluating bedinvetmab, a canine anti-nerve growth factor monoclonal antibody","volume":"50","author":"Michels","year":"2023","journal-title":"Veterinary Anaesthesia and Analgesia"},{"key":"10.1016\/j.vas.2026.100872_bib0030","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1111\/jvim.13923","article-title":"Evaluation of clinical metrology instrument in dogs with osteoarthritis","volume":"30","author":"Muller","year":"2016","journal-title":"Journal of Veterinary Internal Medicine"},{"key":"10.1016\/j.vas.2026.100872_bib0031","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1111\/jvim.13948","article-title":"A prospective, randomized, masked, placebo-controlled multisite clinical study of grapiprant, an EP4 prostaglandin receptor antagonist (PRA), in dogs with osteoarthritis","volume":"30","author":"Rausch-Derra","year":"2016","journal-title":"Journal of Veterinary Internal Medicine"},{"key":"10.1016\/j.vas.2026.100872_bib0032","doi-asserted-by":"crossref","DOI":"10.1186\/1746-6148-8-162","article-title":"Clinical validity of outcome pain measures in naturally occurring canine osteoarthritis","volume":"8","author":"Rialland","year":"2012","journal-title":"BMC Veterinary Research"},{"key":"10.1016\/j.vas.2026.100872_bib0033","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s40122-024-00592-8","article-title":"Clinical assessment of osteoarthritis pain: Contemporary scenario, challenges, and future perspectives","volume":"13","author":"Sethi","year":"2024","journal-title":"Pain and Therapy"},{"key":"10.1016\/j.vas.2026.100872_bib0034","series-title":"Retrieved from Immunogenicity Testing of Therapeutic Protein Products \u2014 Developing and Validating Assays for Anti-Drug Antibody Detection","year":"2019"},{"key":"10.1016\/j.vas.2026.100872_bib0035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0058125","article-title":"Evaluation of construct and criterion validity for the 'Liverpool Osteoarthritis in Dogs' (LOAD) clinical metrology instrument and comparison to two other instruments","volume":"8","author":"Walton","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.vas.2026.100872_bib0036","doi-asserted-by":"crossref","DOI":"10.3389\/fvets.2021.769112","article-title":"Linguistic validation of the canine brief pain inventory (CBPI) for global use","volume":"8","author":"Wells","year":"2021","journal-title":"Frontiers in Veterinary Science"},{"key":"10.1016\/j.vas.2026.100872_bib0037","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/jsap.13500","article-title":"Identification of canine osteoarthritis using an owner-reported questionnaire and treatment monitoring using functional mobility tests","volume":"63","author":"Wright","year":"2022","journal-title":"Journal of Small Animal Practice"}],"container-title":["Veterinary and Animal Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451943X26003017?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451943X26003017?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T19:39:21Z","timestamp":1794339561000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2451943X26003017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":37,"alternative-id":["S2451943X26003017"],"URL":"https:\/\/doi.org\/10.1016\/j.vas.2026.100872","relation":{},"ISSN":["2451-943X"],"issn-type":[{"value":"2451-943X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prospective, randomized, placebo-controlled, multicenter, double-blind, parallel-group, registration field trial evaluating izenivetmab, a caninized anti-nerve growth factor monoclonal antibody, administered quarterly to dogs with naturally occurring osteoarthritis","name":"articletitle","label":"Article Title"},{"value":"Veterinary and Animal Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vas.2026.100872","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100872"}}